Long-term effects of destransulfate LDL apheresis on LDL-C, HDL-C and carotid echotomografy in a young patient with heterozygous Familial Hypercholesterolemia

被引：0
|
作者：
Galetti, C [1 ]
Mussoni, C [1 ]
Parasyris, I [1 ]
Nativio, V [1 ]
Fiorito, A [1 ]
Gaddi, A [1 ]
机构：
[1] Univ Bologna, Dipartimento Med Clin & Biotecnol Applicata, Ctr Aterosclerosi G Descovich, Bologna, Italy
来源：
ATHEROSCLEROSIS | 1999年 / 144卷
关键词：
D O I：
10.1016/S0021-9150(99)80753-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 197
页数：1
相关论文
共 50 条
  • [41] Long-term reduction of C-reactive protein concentration by regular LDL apheresis
    Otto, C
    Geiss, HC
    Empen, K
    Parhofer, KG
    ATHEROSCLEROSIS, 2004, 174 (01) : 151 - 156
  • [42] Effects of cumin extract on oxLDL, paraoxanase 1 activity, FBS, total cholesterol, triglycerides, HDL-C, LDL-C, Apo A1, and Apo B in in the patients with hypercholesterolemia
    Samani, Keihan Ghatreh
    Farrokhi, Effat
    INTERNATIONAL JOURNAL OF HEALTH SCIENCES-IJHS, 2014, 8 (01): : 39 - 43
  • [43] Effects of aerobic exercise on TC, HDL-C, LDL-C and TG in patients with hyperlipidemia A protocol of systematic review and meta-analysis
    Zhao, Shaoping
    Zhong, Jiao
    Sun, Caihong
    Zhang, Junping
    MEDICINE, 2021, 100 (10) : E25103
  • [44] Safety and efficacy of long-term very low achieved LDL-C in the IMPROVE IT trial
    Giugliano, R. P.
    Wiviott, S. D.
    Blazing, M. A.
    Murphy, S. A.
    Zhou, J.
    White, J. A.
    Musliner, T. A.
    Tershakovec, A. J.
    Cannon, C. P.
    Braunwald, E.
    EUROPEAN HEART JOURNAL, 2015, 36 : 2 - 2
  • [45] Long-term effects of LDL-apheresis treatment and morphologic changes of coronary atherosclerotic lesions in two brothers of homozygous patients with familial hypercholesterolemia
    Higashikata, T
    Miwa, K
    Kawashiri, M
    Katsuda, S
    Takata, M
    Inazu, A
    Koizumi, J
    Mabuchi, H
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 172 - 173
  • [46] Long-term (14 years) effect of LDL apheresis on obstructive changes in aortocoronary saphenous-vein bypass grafts in a case of heterozygous familial hypercholesterolemia with the LDL, receptor Proline664 to leucine mutation
    Takahashi, K
    Kobayashi, J
    Bujo, H
    Takahashi, M
    Taira, K
    Kaneko, K
    Tashiro, J
    Shinomiya, M
    Miyazaki, A
    Saito, Y
    INTERNAL MEDICINE, 2000, 39 (10) : 804 - 809
  • [47] Reduction of LDL-C levels with AMG-145, a monoclonal antibody against PCSK9, in heterozygous familial hypercholesterolemia: the RUTHERFORD study
    Rhainds, David
    Tardif, Jean-Claude
    CLINICAL LIPIDOLOGY, 2013, 8 (05) : 513 - 517
  • [48] Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry
    Vrablik, Michal
    Raslova, Katarina
    Vohnout, Branislav
    Blaha, Vladimir
    Satny, Martin
    Kyselak, Ondrej
    Vaclova, Martina
    Urbanek, Robin
    Maskova, Jana
    Soska, Vladimir
    Freiberger, Tomas
    ATHEROSCLEROSIS, 2018, 277 : 355 - 361
  • [49] LDL-C Lowering with Evolocumab and Arterial Aneurysms: Long-Term Analysis from the FOURIER Trial
    Gaba, Prakriti
    Zimerman, Andre
    O'Donoghue, Michelle
    Giugliano, Robert
    Murphy, Sabina
    Kuder, Julia
    Monsalvo, Maria Laura
    Flores-Arredondo, Jose
    Atar, Dan
    Keech, Anthony
    Sabatine, Marc
    Marston, Nicholas
    Bergmark, Brian
    CIRCULATION, 2024, 150
  • [50] The effect of LDL-C/HDL-C ratio on severity of coronary artery disease and 2-year long-term prognosis in patients with premature coronary heart disease---a multicenter, observational results
    Xu, J.
    Jing, C.
    Yingxian, L.
    Ying, S.
    Lin, J.
    Shaodi, Y.
    Wenyu, G.
    Yi, Y.
    Sida, J.
    Deshan, Y.
    Peizhi, W.
    Jianxin, L.
    Xueyan, Z.
    Zhenyu, L.
    Jinqing, Y.
    EUROPEAN HEART JOURNAL, 2023, 44
12345